Literature DB >> 27414009

Research to Practice Implications of High-Risk Genotypes for Beryllium Sensitization and Disease.

Kathleen Kreiss1, Ethan D Fechter-Leggett, Erin C McCanlies, Christine R Schuler, Ainsley Weston.   

Abstract

OBJECTIVE: Beryllium workers may better understand their genetic susceptibility to chronic beryllium disease (CBD) expressed as population-based prevalence, rather than odds ratios from case-control studies.
METHODS: We calculated CBD prevalences from allele-specific DNA sequences of 853 workers for Human Leukocyte Antigen (HLA)-DPB1 genotypes and groups characterized by number of E69-containing alleles and by calculated surface electronegativity of HLA-DPB1.
RESULTS: Of 18 groups of at least 10 workers with specific genotypes, CBD prevalence was highest, 72.7%, for the HLA-DPB102:01:02/DPB117:01 genotype. Population-based grouped genotypes with two E69 alleles wherein one allele had -9 surface charge had a beryllium sensitization (BeS) of 52.6% and a CBD prevalence of 42.1%.
CONCLUSIONS: The high CBD and BeS prevalences associated with -9-charged E69 alleles and two E69s suggest that workers may benefit from knowing their genetic susceptibility in deciding whether to avoid future beryllium exposure.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27414009      PMCID: PMC5339739          DOI: 10.1097/JOM.0000000000000805

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  33 in total

1.  Racial differences in prevalence of a supratypic HLA-genetic marker immaterial to pre-employment testing for susceptibility to chronic beryllium disease.

Authors:  Ainsley Weston; James Ensey; Kathleen Kreiss; Channa Keshava; Erin McCanlies
Journal:  Am J Ind Med       Date:  2002-06       Impact factor: 2.214

2.  DNA-sequence determination of exon 2 of a novel HLA-DPB1 allele, HLA-DPB1*0403.

Authors:  Ainsley Weston; James S Ensey; Bonnie L Frye
Journal:  DNA Seq       Date:  2005-06

3.  Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers.

Authors:  Christine R Schuler; M Abbas Virji; David C Deubner; Marcia L Stanton; Aleksandr B Stefaniak; Gregory A Day; Ji Young Park; Michael S Kent; Rachel Sparks; Kathleen Kreiss
Journal:  Scand J Work Environ Health       Date:  2011-08-29       Impact factor: 5.024

4.  Exposure and genetics increase risk of beryllium sensitisation and chronic beryllium disease in the nuclear weapons industry.

Authors:  Michael V Van Dyke; John W Martyny; Margaret M Mroz; Lori J Silveira; Matt Strand; Donna L Cragle; William G Tankersley; Susan M Wells; Lee S Newman; Lisa A Maier
Journal:  Occup Environ Med       Date:  2011-04-02       Impact factor: 4.402

Review 5.  Beryllium: a modern industrial hazard.

Authors:  Kathleen Kreiss; Gregory A Day; Christine R Schuler
Journal:  Annu Rev Public Health       Date:  2007       Impact factor: 21.981

6.  Impact of negatively charged patches on the surface of MHC class II antigen-presenting proteins on risk of chronic beryllium disease.

Authors:  James A Snyder; Eugene Demchuk; Erin C McCanlies; Christine R Schuler; Kathleen Kreiss; Michael E Andrew; Bonnie L Frye; James S Ensey; Marcia L Stanton; Ainsley Weston
Journal:  J R Soc Interface       Date:  2008-07-06       Impact factor: 4.118

7.  Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease.

Authors:  Lisa A Maier; Dierdre S McGrath; Hiroe Sato; Penny Lympany; Ken Welsh; Roland Du Bois; Lori Silveira; Andrew P Fontenot; Richard T Sawyer; Eric Wilcox; Lee S Newman
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

Review 8.  T cell recognition of beryllium.

Authors:  Shaodong Dai; Michael T Falta; Natalie A Bowerman; Amy S McKee; Andrew P Fontenot
Journal:  Curr Opin Immunol       Date:  2013-08-23       Impact factor: 7.486

Review 9.  A reconsideration of acute Beryllium disease.

Authors:  Kristin J Cummings; Aleksandr B Stefaniak; M Abbas Virji; Kathleen Kreiss
Journal:  Environ Health Perspect       Date:  2009-04-28       Impact factor: 9.031

Review 10.  Electrostatic potential on human leukocyte antigen: implications for putative mechanism of chronic beryllium disease.

Authors:  James A Snyder; Ainsley Weston; Sally S Tinkle; Eugene Demchuk
Journal:  Environ Health Perspect       Date:  2003-11       Impact factor: 9.031

View more
  2 in total

1.  NIOSH's Respiratory Health Division: 50 years of science and service.

Authors:  Kristin J Cummings; Doug O Johns; Jacek M Mazurek; Frank J Hearl; David N Weissman
Journal:  Arch Environ Occup Health       Date:  2018-12-02       Impact factor: 1.663

2.  HLA-DPB1 E69 genotype and exposure in beryllium sensitisation and disease.

Authors:  James Crooks; Margaret M Mroz; Michael VanDyke; Alison McGrath; Christine Schuler; Erin C McCanlies; M Abbas Virji; Kenneth D Rosenman; Milton Rossman; Carol Rice; Dimitri Monos; Tasha E Fingerlin; Lisa A Maier
Journal:  Occup Environ Med       Date:  2021-09-17       Impact factor: 4.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.